Secondary efficacy evaluation method
postprandial blood glucose, Diabetes
INSULIN RESISTANCE, DIABETES
The change in the parameters (postprandial blood glucose, glycated hemoglobin (HbAlc), insulin, C-peptide, lipids) at the end of dosing compared to the baseline value was analyzed using student's Furthermore, a stratified analysis was performed based on fasting hyperglycemic participants with a FBG > 110 mg/dL on the basis that the median FBG at the baseline was 110 mg/dL. The median HOMA-IR at baseline was 1.66, which was clinically consistent with the value determined by the Japanese Diabetes Association for normal insulin resistance [